Secondary Myelofibrosis Completed Phase 2 Trials for Busulfan (DB01008)

IndicationStatusPhase
DBCOND0030964 (Secondary Myelofibrosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00611351Busulfan, Cyclophosphamide, and Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic CancerTreatment
NCT01093586Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment